bioMérieux S.A. (OTCMKTS:BMXMF) Sees Significant Decrease in Short Interest

bioMérieux S.A. (OTCMKTS:BMXMF) was the recipient of a significant drop in short interest in the month of December. As of December 31st, there was short interest totalling 118,300 shares, a drop of 19.1% from the December 15th total of 146,200 shares. Based on an average daily trading volume, of 100 shares, the short-interest ratio is presently 1,183.0 days.

bioMérieux Price Performance

BMXMF stock remained flat at $110.92 during midday trading on Friday. bioMérieux has a 12 month low of $93.50 and a 12 month high of $122.52. The firm has a fifty day simple moving average of $105.26 and a two-hundred day simple moving average of $108.71.

bioMérieux Company Profile

bioMérieux SA develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries.